ArchivesCategories |
Back to Blog
Within our intricate immune system lies a group of extraordinary defenders known as natural killer (NK) cells. These versatile cells have captured the attention of scientists and immunologists due to their remarkable abilities. Without the need for prior exposure or specific recognition of antigens, natural killer cells act as vigilant guardians, swiftly identifying and eliminating infected cells and cancerous threats.
Natural Killer Cells are a subset of lymphocytes, a type of white blood cell crucial for immune defense. Unlike their counterparts, T and B lymphocytes, natural killer cells are part of the innate immune response. They earned their name due to their inherent ability to directly kill target cells without prior sensitization. Natural killer cells originate from the bone marrow, where they undergo maturation and differentiation. Once mature, they circulate throughout the body, patrolling various tissues, including the spleen, liver, lymph nodes, and blood. Their distinguishing feature is the presence of surface receptors, which allow them to recognize and interact with target cells. Unlike the adaptive immune system's complex recognition process, natural killer cells employ a unique strategy to distinguish healthy cells from those requiring elimination. They possess a repertoire of activating and inhibitory receptors, which function together to assess the "self" status of cells. Healthy cells express specific molecules, known as major histocompatibility complex class I (MHC-I), on their surface. In normal circumstances, MHC-I molecules bind to inhibitory receptors on natural killer cells, signaling the immune system not to attack. However, when an infected or cancerous cell undergoes alterations, MHC-I expression can be reduced or lost entirely, thereby relieving the inhibitory signal. This absence of MHC-I triggers activation signals, allowing natural killer cells to unleash their cytotoxic weaponry. Activation receptors on natural killer cells recognize stress-induced molecules or altered surface proteins expressed by abnormal cells. Once activated, natural killer cells swiftly release a cocktail of potent cytotoxic substances, such as perforins and granzymes, causing cell death. Natural killer cells boast a repertoire of effector functions that contribute to their exceptional versatility in combating threats. Their primary role is to induce target cell death, a process known as apoptosis. Through the release of perforins and granzymes, natural killer cells create pores in the target cell membrane, facilitating the entry of cytotoxic molecules and initiating programmed cell death. Additionally, natural killer cells possess the ability to produce a variety of cytokines, chemical messengers that regulate immune responses. These cytokines include interferon-gamma (IFN-γ), which enhances the immune response and promotes inflammation, as well as other cytokines that regulate the activation and recruitment of other immune cells. Due to their potent cytotoxic abilities and cytokine production, natural killer cells have attracted considerable interest in clinical research. Scientists are investigating the potential of natural killer cell-based immunotherapies in various diseases, including cancer. One area of focus is adoptive cell transfer (ACT), a technique where natural killer cells are isolated, expanded, and reintroduced into the patient. This approach has shown promising results in certain malignancies, especially hematological cancers like leukemia and lymphoma. The infusion of ex vivo activated natural killer cells can enhance the patient's immune response, leading to improved outcomes. Adoptive cell transfer (ACT) is a therapeutic approach that involves the isolation, expansion, and infusion of specific immune cells into a patient to enhance their immune response against diseases, particularly cancer. The goal of ACT is to bolster the patient's immune system by providing a greater number of functional and effective immune cells. Furthermore, recent advancements in genetic engineering techniques have enabled the modification of natural killer cells to enhance their efficacy. Chimeric antigen receptor (CAR)- natural killer cells, similar to CAR-T cells, are engineered to express receptors that specifically recognize tumor-associated antigens. This strategy holds great potential for targeted cancer therapy and is being explored in clinical trials.
0 Comments
Read More
Leave a Reply. |